Acrospire Investment Management LLC - CHINA CORD BLOOD CORP ownership

CHINA CORD BLOOD CORP's ticker is CO and the CUSIP is G21107100. A total of 29 filers reported holding CHINA CORD BLOOD CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of CHINA CORD BLOOD CORP
ValueSharesWeighting
Q2 2017$27,000
-43.8%
2,835
-60.3%
0.02%
-37.5%
Q1 2017$48,000
-60.3%
7,135
-63.9%
0.04%
-20.0%
Q4 2016$121,00019,7630.05%
Other shareholders
CHINA CORD BLOOD CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 830,000$5,113,0000.37%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 188,330$1,160,0000.26%
Rotella Capital Management, Inc. 10,394$64,0000.05%
ACADIAN ASSET MANAGEMENT LLC 1,213,701$7,480,0000.04%
GSA CAPITAL PARTNERS LLP 149,123$919,0000.04%
FINANCIAL COUNSELORS INC 81,830$504,0000.03%
FIRST NEW YORK SECURITIES LLC /NY 6,500$40,040,0000.02%
Verition Fund Management LLC 12,779$79,0000.01%
TFS CAPITAL LLC 14,453$89,0000.01%
ADVISORY RESEARCH INC 128,150$789,0000.01%
View complete list of CHINA CORD BLOOD CORP shareholders